Alpha 2.0
Login Register
» Authors » Pedro A Velasquez-Mieyer

Pedro A Velasquez-Mieyer

Explore the profile of Pedro A Velasquez-Mieyer including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 44
Followers 0
Related Specialties
Nursing
Pediatrics
Pharmacology
Top 10 Co-Authors
Claudia P Neira
Ramfis Nieto-Martinez
Patricia A Cowan
Jeffrey I Mechanick
Xichen Mou
Robert H Lustig
Peter Bacchetti
Andres E Velasquez
Cori Cohen Grant
Bruce S Alpert
Published In
Nutrients
J Pediatr
J Am Acad Nurse Pract
Diabetes Care
Expert Opin Pharmacother
Affiliations
Soon will be listed here.
Recent Articles
1.
Disparities in the Cardiometabolic Impact of Adiposity among African American and Hispanic Adolescents
Velasquez-Mieyer P, Nieto-Martinez R, Velasquez A, Mou X, Young-Moss S, Mechanick J, et al.
Nutrients . 2024 Sep; 16(18). PMID: 39339743
As adiposity increases in youth, so does the prevalence of cardiometabolic risk factors (CMRFs). The etiology of adiposity-based chronic disease and CMRFs includes ethnoracial disparities that are rarely considered in...
2.
Relative Body Mass Index Improves the BMI Percentile Performance for Detection and Monitoring of Excess Adiposity in Adolescents
Velasquez-Mieyer P, Nieto-Martinez R, Neira C, De Oliveira-Gomes D, Velasquez Rodriguez A, Ugel E, et al.
Nutrients . 2024 Mar; 16(5). PMID: 38474830
Obesity is defined as excess adipose tissue; however, commonly used methods may under-detect adiposity in adolescents. This study compared the performance of body mass index percentile (BMI%) and relative body...
3.
Impact of a Multidisciplinary Approach on Cardiometabolic Risk Reduction in a Multiracial Cohort of Adults: A 1-Year Pilot Study
Nieto-Martinez R, Velasquez-Rodriguez A, Neira C, Mou X, Neira A, Garcia G, et al.
Nutrients . 2022 Aug; 14(16). PMID: 36014896
Evidence examining specific effects of a multidisciplinary team (MDT) on cardiometabolic risk factors (CMRFs) among multi-ethnic patients in real-world clinical settings is lacking. This one-year retrospective chart review (2018) analyzed...
4.
The prevalence of impaired glucose metabolism in Hispanics with two or more risk factors for metabolic syndrome in the primary care setting
Neira C, Hartig M, Cowan P, Velasquez-Mieyer P
J Am Acad Nurse Pract . 2009 Mar; 21(3):173-8. PMID: 19302694
Purpose: The purposes of this observational prospective study were (a) to identify the prevalence of undiagnosed impaired glucose metabolism (IGM) including impaired fasting glucose (IFG), impaired glucose tolerance (IGT), and...
5.
Biphasic insulin aspart 30 for the treatment of type 1 diabetes mellitus
Velasquez-Mieyer P, Neira C
Expert Opin Pharmacother . 2008 Aug; 9(13):2377-82. PMID: 18710361
Background: Type 1 diabetes mellitus is associated with acute and long-term complications, to which pre- and postprandial hyperglycemia are independent contributors. The objective of this review was to evaluate evidence-based...
6.
Racial disparity in glucagon-like peptide 1 and inflammation markers among severely obese adolescents
Velasquez-Mieyer P, Cowan P, Perez-Faustinelli S, Nieto-Martinez R, Villegas-Barreto C, Tolley E, et al.
Diabetes Care . 2008 Jan; 31(4):770-5. PMID: 18184905
Objective: Compared with Caucasians, obese African-American adolescents have a higher risk for type 2 diabetes. Subclinical inflammation and reduced glucagon-like peptide 1 (GLP-1) concentration are linked to the pathogenesis of...
7.
Insulin dynamics predict body mass index and z-score response to insulin suppression or sensitization pharmacotherapy in obese children
Lustig R, Mietus-Snyder M, Bacchetti P, Lazar A, Velasquez-Mieyer P, Christensen M
J Pediatr . 2006 Jan; 148(1):23-9. PMID: 16423593
Objective: To assess the use of oral glucose tolerance testing (OGTT) to predict efficacy of insulin sensitization (metformin) or suppression (octreotide) because insulin resistance and insulin hypersecretion may impact pharmacotherapeutic...